Literature DB >> 35218672

In vivo assessment of hypertensive nephrosclerosis using ultrasound localization microscopy.

Lanyan Qiu1, Jingke Zhang2, Yi Yang2, Hong Zhang1, Fu-Feng Lee2, Qiong He2,3, Chengwu Huang4, Lijie Huang2, Linxue Qian1, Jianwen Luo2.   

Abstract

PURPOSE: As a typical chronic kidney disease (CKD), hypertensive nephrosclerosis (HN) is a common syndrome of hypertension, characterized by chronic kidney microvascular damage. Early diagnosis of microvascular damage using conventional ultrasound imaging encounters challenges in sensitivity and specificity owing to the inherent diffraction limit. Ultrasound localization microscopy (ULM) has been developed to obtain microvasculature and microvascular hemodynamics within the kidney, and would be a promising tool for the early diagnosis of CKD.
METHODS: In this study, the advantage of quantitative indexes obtained by using ULM (mean arterial blood flow speeds of different segments of interlobular arteries) over indexes obtained using conventional clinical serum (β2-microglobulin, serum urea nitrogen, and creatinine) and urine (24-h urine volume and urine protein) tests and ultrasound Doppler imaging (peak systolic velocity [PSV], end-diastolic velocity [EDV], and resistance index [RI]) and contrast-enhanced ultrasound imaging (CEUS; rise time [RT], peak intensity [IMAX], mean transit time [mTT], and area under the time-intensity curve [AUC]) for early diagnosis of HN were investigated. Examinations were carried out on six spontaneously hypertensive rats (SHR) and five normal Wistar-Kyoto (WKY) rats at the age of 10 weeks.
RESULTS: The experimental results show that the indicators derived from conventional clinical inspections (serum and urine tests) and ultrasound imaging (PSV, EDV, RI, RT, IMAX, mTT, and AUC) do not show significant difference between hypertensive and healthy rats (p > 0.05), while the TTP of the SHR group (28.52 ± 5.52 s) derived from CEUS is significantly higher than that of the WKY group (18.68 ± 7.32 s; p < 0.05). The mean blood flow speed in interlobular artery of SHR (12.47 ± 1.06 mm/s) derived from ULM is significantly higher than that of WKY rats (10.13 ± 1.17 mm/s; p < 0.01).
CONCLUSION: The advantages of ULM over conventional clinical inspections and ultrasound imaging methods for early diagnosis of HN were validated. The quantitative results show that ULM can effectively diagnose HN at the early stage by detecting the blood flow speed changes of interlobular arteries. ULM may promise a reliable technique for early diagnosis of HN in the future.
© 2022 American Association of Physicists in Medicine.

Entities:  

Keywords:  hypertensive nephrosclerosis; microbubble; renal microvasculature; ultrasound imaging; ultrasound localization microscopy

Mesh:

Year:  2022        PMID: 35218672     DOI: 10.1002/mp.15583

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  3 in total

1.  Super-Resolution Ultrasound Imaging Can Quantify Alterations in Microbubble Velocities in the Renal Vasculature of Rats.

Authors:  Sofie Bech Andersen; Iman Taghavi; Stinne Byrholdt Søgaard; Carlos Armando Villagómez Hoyos; Michael Bachmann Nielsen; Jørgen Arendt Jensen; Charlotte Mehlin Sørensen
Journal:  Diagnostics (Basel)       Date:  2022-04-28

2.  Impact of Selective Renal Afferent Denervation on Oxidative Stress and Vascular Remodeling in Spontaneously Hypertensive Rats.

Authors:  Lu-Lu Wu; Yue Zhang; Xiu-Zhen Li; Xin-Li Du; Ying Gao; Jing-Xiao Wang; Xiao-Li Wang; Qi Chen; Yue-Hua Li; Guo-Qing Zhu; Xiao Tan
Journal:  Antioxidants (Basel)       Date:  2022-05-20

3.  Super-Resolution Ultrasound Imaging Provides Quantification of the Renal Cortical and Medullary Vasculature in Obese Zucker Rats: A Pilot Study.

Authors:  Stinne Byrholdt Søgaard; Sofie Bech Andersen; Iman Taghavi; Carlos Armando Villagómez Hoyos; Christina Christoffersen; Kristoffer Lindskov Hansen; Jørgen Arendt Jensen; Michael Bachmann Nielsen; Charlotte Mehlin Sørensen
Journal:  Diagnostics (Basel)       Date:  2022-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.